Pharma Tech Industries

Executive Summary

Pharma Tech Industries (PTI) is a private US-based CDMO specializing in non-sterile dry powder blending, formulation, and high-speed packaging for pharmaceutical, OTC, and nutritional products. Founded in 2010 and headquartered in San Francisco, PTI provides end-to-end services from development to commercial-scale production, focusing on powder-based delivery systems such as sachets, stick packs, tablets, and capsules. As a contract manufacturer, PTI benefits from the growing trend of pharmaceutical outsourcing, particularly for solid oral dosage forms. However, the company operates in a competitive landscape with larger, well-funded CDMOs. PTI's niche focus on dry powder technologies and its ability to handle small to mid-scale production runs may differentiate it for clients seeking specialized expertise. With no disclosed funding rounds or revenue data, the company appears to be a smaller player; its success depends on securing long-term contracts and expanding its client base. The conviction score reflects moderate confidence given the fragmented CDMO market and PTI's limited public information.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a new multi-year manufacturing contract with a major pharma or biotech company45% success
• Q4 2026Expansion of manufacturing capacity or facility upgrades to meet growing demand60% success
• Q4 2026Receiving FDA approval for a client's drug product manufactured by PTI, demonstrating quality and regulatory compliance50% success